Study of ZE74-0282 for Patients With JAK2 V617F Positive Blood Cancers

Clinical trial NCT07529951 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07529951
Sponsor: Eilean Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Polycythemia Vera (PV)Myelofibrosis (MF)

Start date: 2026-05-15
Primary completion: 2028-09-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.